3//SEC Filing
Frazier Life Sciences VIII, L.P. 3
Accession 0001209191-18-052219
CIK 0001724344other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 8:39 PM ET
Size
14.8 KB
Accession
0001209191-18-052219
Insider Transaction Report
Form 3
Frazier Life Sciences VIII, L.P.
10% Owner
Holdings
Series B-1 Tranche B Convertible Preferred Stock
→ Common Stock (6,651,574 underlying)Series B-1 Tranche A Convertible Preferred Stock
→ Common Stock (5,212,833 underlying)Series B Convertible Preferred Stock
→ Common Stock (7,000,000 underlying)
FHM LIFE SCIENCES VIII, L.L.C.
10% Owner
Holdings
Series B-1 Tranche B Convertible Preferred Stock
→ Common Stock (6,651,574 underlying)Series B-1 Tranche A Convertible Preferred Stock
→ Common Stock (5,212,833 underlying)Series B Convertible Preferred Stock
→ Common Stock (7,000,000 underlying)
FHM LIFE SCIENCES VIII, L.P.
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock (7,000,000 underlying)Series B-1 Tranche B Convertible Preferred Stock
→ Common Stock (6,651,574 underlying)Series B-1 Tranche A Convertible Preferred Stock
→ Common Stock (5,212,833 underlying)
Heron Patrick J
10% Owner
Holdings
Series B-1 Tranche B Convertible Preferred Stock
→ Common Stock (6,651,574 underlying)Series B Convertible Preferred Stock
→ Common Stock (7,000,000 underlying)Series B-1 Tranche A Convertible Preferred Stock
→ Common Stock (5,212,833 underlying)
Footnotes (2)
- [F1]Each share of Series B Convertible Preferred Stock, Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a 20.728-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Heron, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.
Issuer
Entasis Therapeutics Holdings Inc.
CIK 0001724344
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001655827
Filing Metadata
- Form type
- 3
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 8:39 PM ET
- Size
- 14.8 KB